These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 6265016)

  • 21. Role of non-selective adenosine receptor blockade and phosphodiesterase inhibition in cisplatin-induced nephrogonadal toxicity in rats.
    Saad SY; Najjar TA; Alashari M
    Clin Exp Pharmacol Physiol; 2004 Dec; 31(12):862-7. PubMed ID: 15659050
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The effect of methylprednisolone on platinum kinetics and urinary enzyme excretion following intravenous cisplatin in vivo and on the growth inhibition of LLC-PK1 cells by cisplatin in vitro.
    Uozumi J; Koikawa Y; Yasumasu T; Tokuda N; Ueda T; Kumazawa J
    Res Exp Med (Berl); 1996; 196(4):211-7. PubMed ID: 8903096
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Urinary excretion of beta 2-microglobulin and N-acetyl-beta-D-glucosaminidase in advanced neuroblastoma patients receiving cis-diamminedichloroplatinum(II).
    Ikeda H; Nagashima K; Okumura H; Takahashi A; Matsuyama S; Nagamachi Y
    Eur J Surg Oncol; 1988 Feb; 14(1):17-20. PubMed ID: 3278937
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Nephrotoxicity of cis-platin comparing young and adult rats.
    Jongejan HT; Provoost AP; Wolff ED; Molenaar JC
    Pediatr Res; 1986 Jan; 20(1):9-14. PubMed ID: 3945520
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Measurement of creatinine clearance and urinary NAG for the evaluation of cis-platinum induced nephrotoxicity].
    Kubota A; Yoshida T; Tsukuda M; Furukawa S; Miyata K; Mochimatsu I; Sawaki S
    Gan To Kagaku Ryoho; 1989 Aug; 16(8 Pt 1):2599-605. PubMed ID: 2774590
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of sodium thiosulfate on the pharmacokinetics of unchanged cisplatin and on the distribution of platinum species in rat kidney: protective mechanism against cisplatin nephrotoxicity.
    Nagai N; Hotta K; Yamamura H; Ogata H
    Cancer Chemother Pharmacol; 1995; 36(5):404-10. PubMed ID: 7634382
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Magnesium attenuates cisplatin-induced nephrotoxicity by regulating the expression of renal transporters.
    Saito Y; Okamoto K; Kobayashi M; Narumi K; Yamada T; Iseki K
    Eur J Pharmacol; 2017 Sep; 811():191-198. PubMed ID: 28529140
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Acute and chronic cisplatin nephropathy in rats.
    Choie DD; Longnecker DS; del Campo AA
    Lab Invest; 1981 May; 44(5):397-402. PubMed ID: 7194946
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Relation of enzyme distribution in the kidney and increase pattern of urinary N-acetyl-beta-D-glucosaminidase (NAG) and gamma-glutamyl transpeptidase (gamma-GTP) activities following CDDP administration].
    Takahashi T; Yoshida K; Nakame Y; Saitoh H
    Hinyokika Kiyo; 1987 Oct; 33(10):1569-74. PubMed ID: 2895573
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Renoprotective effects of angiotensin receptor blocker and stem cells in acute kidney injury: Involvement of inflammatory and apoptotic markers.
    Sherif IO; Al-Mutabagani LA; Alnakhli AM; Sobh MA; Mohammed HE
    Exp Biol Med (Maywood); 2015 Dec; 240(12):1572-9. PubMed ID: 25825359
    [TBL] [Abstract][Full Text] [Related]  

  • 31. cis-Dichlorodiammineplatinum nephrotoxicity in rats of different ages.
    Braunlich H; Kuo CH; Slocombe R; Hook JB
    Res Commun Chem Pathol Pharmacol; 1984 May; 44(2):279-91. PubMed ID: 6539942
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Time course of the binding of platinum to subfractions of the kidney cytosol in the cisplatin-treated rat.
    Mason R; Hogg S; Edwards IR
    Res Commun Chem Pathol Pharmacol; 1986 Apr; 52(1):51-8. PubMed ID: 3715197
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Protection against cisplatin nephrotoxicity by prochlorperazine.
    Kramer RA
    Cancer Chemother Pharmacol; 1989; 25(3):156-60. PubMed ID: 2598405
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Protective action of glycine in cisplatin nephrotoxicity.
    Heyman SN; Rosen S; Silva P; Spokes K; Egorin MJ; Epstein FH
    Kidney Int; 1991 Aug; 40(2):273-9. PubMed ID: 1942775
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pharmacokinetics of cis-diamminedichloroplatinum(II) after administration in hypertonic saline.
    Bajorin DF; Bosl GJ; Alcock NW; Niedzwiecki D; Gallina E; Shurgot B
    Cancer Res; 1986 Nov; 46(11):5969-72. PubMed ID: 3756934
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mechanism of cisplatin nephrotoxicity.
    Weiner MW; Jacobs C
    Fed Proc; 1983 Oct; 42(13):2974-8. PubMed ID: 6684595
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Alteration of tissue disposition of cadmium by chelating agents.
    Klaassen CD; Waalkes MP; Cantilena LR
    Environ Health Perspect; 1984 Mar; 54():233-42. PubMed ID: 6734558
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Disposition and distribution of platinum following parenteral administration of cis-dichlorodiammineplatinum(II) to animals.
    Litterst CL; LeRoy AF; Guarino AM
    Cancer Treat Rep; 1979; 63(9-10):1485-92. PubMed ID: 498147
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A comparison in rodents of renal and intestinal toxicity of cisplatin and a new water-soluble antitumor platinum complex: N-methyl-iminodiacetato-diaminocyclohexane platinum (II).
    Newman RA; Khokhar AR; Sunderland BA; Travis EL; Bulger RE
    Toxicol Appl Pharmacol; 1986 Jul; 84(3):454-63. PubMed ID: 3726868
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The pharmacology of 2,3-dimercaptosuccinic acid and its potential use in arsenic poisoning.
    Graziano JH; Cuccia D; Friedheim E
    J Pharmacol Exp Ther; 1978 Dec; 207(3):1051-5. PubMed ID: 215741
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.